Authors
Natalie S. Adamczyk, Shingo Ishihara, Alia M. Obeidat, Daniel B. Hoffman, Brian T. David, Dongjun Ren, Richard J. Miller, Anne-Marie Malfait, Rachel E. Miller
Lab
Journal
British Journal of Pharmacology
Abstract
Figure S2. Baseline comparison across days. All mice were evaluated for the baseline knee withdrawal threshold on day 1. A cross-over study design was used such that mice (n = 8 mice per group) were divided into vehicle and FM1-43 groups for an injection on day 2; on day 6 mice received the opposite injection from day 2. All mice were tested pre-injection on days 2 and 6 to make sure that there was no effect of the order of injection on the baseline knee hyperalgesia. A) Knee withdrawal threshold every morning prior to injection WT sham mice. B) Knee withdrawal threshold every morning prior to injection WT PMX mice. C) Knee withdrawal threshold every morning prior to injection Piezo2cko PMX mice. A-C) One-way repeated measures ANOVA with Tukeyposttest. Each dot represents an individual mouse. Star points indicate a mouse receiving FM1-43 that afternoon. Female = purple; Male = green. The maximum of the assay is indicated with a dotted line (450 g).
Keywords/Topics
nociceptor; osteoarthritis; pain; Piezo2; sensitization
BIOSEB Instruments Used:
Static Weight Bearing Touch: Incapacitance Test (BIO-SWB-TOUCH-M)
Source :
https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.70306
Congrès & Meetings 2026 